Cargando…
Pharmacogenomic strategy for individualizing antidepressant therapy
Despite remarkable progress, pharmacotherapy in general, including that for the treatment of depressive conditions, has often ignored the magnitude and clinical significance of the huge interindividual variations in pharmacokinetics and pharmacodynamics, resulting in poor compliance, suboptimal ther...
Autores principales: | Lin, Keh-Ming, Perils, Roy H., Wan, Yu-Jui Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181891/ https://www.ncbi.nlm.nih.gov/pubmed/19170397 |
Ejemplares similares
-
Pharmacogenomics of antidepressant treatment effects
por: Licinio, Julio, et al.
Publicado: (2011) -
Pharmacogenomics in depression and antidepressants
por: Bondy, Brigitta
Publicado: (2005) -
Translating Pharmacogenomics: Challenges on the Road to the Clinic
por: Swen, Jesse J, et al.
Publicado: (2007) -
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
por: Correia, Catarina, et al.
Publicado: (2022) -
Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments
por: Lin, Eugene, et al.
Publicado: (2021)